Article
Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2012
Fedirko Veronika, Riboli Elio, Tjønneland Anne, Ferrari Pietro, Olsen Anja, Bueno-de-Mesquita H Bas, van Duijnhoven Fränzel J B, Norat Teresa, Jansen Eugène H J M, Dahm Christina C, Overvad Kim, Boutron-Ruault Marie-Christine, Clavel-Chapelon Françoise, Racine Antoine, Lukanova Annekatrin, Teucher Birgit, Boeing Heiner, Aleksandrova Krasimira, Trichopoulou Antonia, Benetou Vassiliki, Trichopoulos Dimitrios, Grioni Sara, Vineis Paolo, Panico Salvatore, Palli Domenico, Tumino Rosario, Siersema Peter D, Peeters Petra H, Skeie Guri, Brustad Magritt, Chirlaque Maria-Dolores, Barricarte Aurelio, Ramón Quirós Jose, Sánchez Maria José, Dorronsoro Miren, Bonet Catalina, Palmqvist Richard, Hallmans Göran, Key Timothy J, Crowe Francesca, Khaw Kay-Tee, Wareham Nick, Romieu Isabelle, McKay James, Wark Petra A, Romaguera Dora, Jenab Mazda
Abstract excerpt
BACKGROUND: Individuals with higher blood 25-hydroxyvitamin D [25(OH)D] levels have a lower risk of developing colorectal cancer (CRC), but the influence of 25(OH)D on mortality after CRC diagnosis is unknown. METHODS: The association between prediagnostic 25(OH)D levels and CRC-specific (N = 444) and overall mortality (N = 541) was prospectively examined among 1,202 participants diagnosed with CRC between 1992...
Read the complete abstract on PubMed